Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
386M
-
Number of holders
-
90
-
Total 13F shares, excl. options
-
18.4M
-
Shares change
-
-182K
-
Total reported value, excl. options
-
$211M
-
Value change
-
-$7.53M
-
Number of buys
-
44
-
Number of sells
-
-34
-
Price
-
$11.44
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q3 2015
99 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q3 2015.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.4M shares
of 386M outstanding shares and own 4.77% of the company stock.
Largest 10 shareholders include Boston Partners (1.55M shares), HEARTLAND ADVISORS INC (1.2M shares), JANUS CAPITAL MANAGEMENT LLC (1.15M shares), Paradice Investment Management LLC (992K shares), ACK Asset Management LLC (928K shares), CARDINAL CAPITAL MANAGEMENT LLC /CT (849K shares), KENNEDY CAPITAL MANAGEMENT, INC. (767K shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (722K shares), ROYCE & ASSOCIATES LLC (596K shares), and Senvest Management, LLC (577K shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.